Proudly accepted into the NVIDIA Inception Program.
This validates LURA — our GPU-accelerated 3D tumor simulation engine — and unlocks NVIDIA’s top-tier GPU resources, technical support, and co-marketing. We’re already running millions of parallel causal experiments in hours on A100s. With Inception, we’re accelerating even harder: deeper TME modeling, sub-100ms screens, and faster pilot rollouts for oncology teams. Momentum building as we raise $2M to put LURA in drug discovery pipelines worldwide.
A new era of spatial intelligence
Tumors are not flat dishes. LURA models penetration, hypoxia, stromal shielding, and compensatory survival in 3D — so resistance is mechanistic, not just a lower number.
Built for teams who ship evidence, not slides
For translational leads and CRO partners who need exports that survive a sponsor review — not another heatmap.
Traditional oncology discovery wastes billions on candidates that fail due to unmodeled 3D barriers and mechanisms. LURA's physics + AI approach cuts through that — delivering 10–20× faster insights, validated accuracy, and sub-second responses so teams focus on winners.
Elisha Sannousi
Co-Founder | Clinical & Translational Engineer (M.S. Translational Medicine, Bioengineering)
Samuel Tandeka
Co-Founder | Engineering Management & Business Development (M.S. Engineering Management) (B.S. Electrical Eng.)
